BACKGROUND: The Centers for Disease Control and Prevention estimates that 1.8% of the US population is infected with hepatitis C virus (HCV), and most are unaware of their infection. GOAL: The goal was to evaluate risk-based HCV screening criteria for clients attending an urban sexually transmitted disease (STD) clinic. STUDY DESIGN: This was a cross-sectional study of HCV prevalence among all STD clinic clients during an 8-month period (September 1999 through April 2000) in San Diego, California. RESULTS: HCV prevalence was 4.9% (165/3367). Clients who reported that they were injecting drug users (IDUs) were much more likely to be HCV-positive than other clients (51% versus 2%; P < 0.001). Selective screening of IDUs, sex partners of IDUs, and persons having received a blood transfusion before 1992 would have identified 70% of HCV-infected clients while screening only 12% of the clinic's attendees. The HCV prevalence among clients with a history of a bacterial STD (in the past 5 years) and no other major risk factors was only 2.5%. CONCLUSION: In STD clinics, integrating risk-based screening into routine clinic services is an efficient way to identify HCV-infected persons.
BACKGROUND: The Centers for Disease Control and Prevention estimates that 1.8% of the US population is infected with hepatitis C virus (HCV), and most are unaware of their infection. GOAL: The goal was to evaluate risk-based HCV screening criteria for clients attending an urban sexually transmitted disease (STD) clinic. STUDY DESIGN: This was a cross-sectional study of HCV prevalence among all STD clinic clients during an 8-month period (September 1999 through April 2000) in San Diego, California. RESULTS:HCV prevalence was 4.9% (165/3367). Clients who reported that they were injecting drug users (IDUs) were much more likely to be HCV-positive than other clients (51% versus 2%; P < 0.001). Selective screening of IDUs, sex partners of IDUs, and persons having received a blood transfusion before 1992 would have identified 70% of HCV-infected clients while screening only 12% of the clinic's attendees. The HCV prevalence among clients with a history of a bacterial STD (in the past 5 years) and no other major risk factors was only 2.5%. CONCLUSION: In STD clinics, integrating risk-based screening into routine clinic services is an efficient way to identify HCV-infectedpersons.
Authors: Brooke E Hoots; Pia D M MacDonald; Lisa B Hightow-Weidman; Peter A Leone; William C Miller Journal: Sex Transm Dis Date: 2012-01 Impact factor: 2.830
Authors: Danielle Horyniak; Karla D Wagner; Richard F Armenta; Jazmine Cuevas-Mota; Erik Hendrickson; Richard S Garfein Journal: Int J Drug Policy Date: 2017-07-03
Authors: W N Southern; M-L Drainoni; B D Smith; C L Christiansen; D McKee; A L Gifford; C M Weinbaum; D Thompson; E Koppelman; S Maher; A H Litwin Journal: J Viral Hepat Date: 2010-05-20 Impact factor: 3.728
Authors: Marcia Russell; Meng-Jinn Chen; Thomas H Nochajski; Maria Testa; Scott J Zimmerman; Patricia S Hughes Journal: Am J Public Health Date: 2009-02-12 Impact factor: 9.308
Authors: William N Southern; Mari-Lynn Drainoni; Bryce D Smith; Elisa Koppelman; M Diane McKee; Cindy L Christiansen; Allen L Gifford; Cindy M Weinbaum; Alain H Litwin Journal: Qual Manag Health Care Date: 2014 Jan-Mar Impact factor: 0.926
Authors: Corina Lelutiu-Weinberger; Enrique R Pouget; Don D C Des Jarlais; Hannah L Cooper; Roberta Scheinmann; Rebecca Stern; Shiela M Strauss; Holly Hagan Journal: Soc Sci Med Date: 2008-12-04 Impact factor: 4.634
Authors: Joanna Buffington; Paula J Murray; Karen Schlanger; Linda Shih; Tracy Badsgard; Robin R Hennessy; Robert Wood; Isaac B Weisfuse; Robert A Gunn Journal: Public Health Rep Date: 2007 Impact factor: 2.792